DeFi expects the acquisition to diversify its revenue streams. Credit: ARMMY PICCA/Shutterstock.

DeFi Technologies has signed a letter of intent (LOI) to acquire a 10% stake in Swiss asset management firm Neuronomics.

Neuronomics specialises in AI-driven quantitative trading strategies that combine artificial intelligence, computational neuroscience, and quantitative finance.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

This strategic move is aimed at expanding DeFi Technologies’ presence in the asset management space and leveraging Neuronomics’ technological expertise.

This investment marks a strategic expansion for DeFi Technologies in the asset management space, building on its previous toe-hold investment in Neuronomics.

The acquisition aligns with the company’s broader goal to strengthen its trading and asset management capabilities, complementing its existing DeFi Alpha arbitrage trading desk.

DeFi Technologies CEO Olivier Roussy Newton said: “We have been a shareholder and partner of Neuronomics since 2023, and can see how Neuronomics’ AI-driven quantitative trading strategies perfectly complement our existing capabilities and align with our broader goals.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“The Investment will deepen the relationship between Neuronomics and DeFi Technologies and will not only enhance our expertise in the trading sector but also diversifies our revenue streams, especially through DeFi Alpha—our specialised arbitrage trading desk that focuses on low-risk opportunities in the cryptocurrency market.

“By integrating Neuronomics’ cutting-edge strategies, we will strengthen our ability to deliver consistent, market-neutral returns while further advancing our position in both traditional and decentralised finance.”

DeFi Technologies’ investment in Neuronomics are subject to customary conditions and regulatory approvals.